Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition.
Hendrick E, Peixoto P, Blomme A, Polese C, Matheus N, Cimino J, Frère A, Mouithys-Mickalad A, Serteyn D, Bettendorff L, Elmoualij B, De Tullio P, Eppe G, Dequiedt F, Castronovo V, Mottet D.
Hendrick E, et al. Among authors: matheus n.
Oncogene. 2017 Aug 24;36(34):4859-4874. doi: 10.1038/onc.2017.103. Epub 2017 Apr 17.
Oncogene. 2017.
PMID: 28414307
Free article.